InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,480.40
(
1.13%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.21%
)
Bitcoin
62,274.82
(
2.51%
)

Replies to post #96823 on Regen BioPharma Inc (RGBP)

Replies to #96823 on Regen BioPharma Inc (RGBP)
icon url

Tonneke

11/11/21 4:24 AM

#96825 RE: PressAnyKey- #96823

i've read a lot but can't understand everything, it's a great result to read, i'm proud of our company, thanks for sharing
icon url

Skiluc

11/11/21 8:33 AM

#96828 RE: PressAnyKey- #96823

Absolutely undeniable. As Are Regen’s NR2F6 patents.

Hello?

Anybody Home?
icon url

Skiluc

11/11/21 10:21 PM

#96907 RE: PressAnyKey- #96823

Had a min to catch up. Wow! What a link:

The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance

https://www.cell.com/cell-reports/fulltext/S2211-1247(15)00920-1

Absolutely undeniable.